Reporting owner · CIK 0001768337
Plott Ronald Todd
Visual SEC Form 4 history across 1 companies, 1 transactions and 1 filings.
DIRPhio Pharmaceuticals Corp.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Aug 26
$17.1K
Transaction texture
Ownership and ticket size
Average P/S size$17.1K
Median P/S size$17.1K
Direct1
Indirect0
Aug 19, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Phio Pharmaceuticals Corp. on Aug 19, 2026 valued at $17,100.
Review SEC filingLatest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
Plott Ronald Todd Insider Activity FAQ
SEC Form 4 context
Who is Plott Ronald Todd?
Plott Ronald Todd is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001768337.
Which companies has Plott Ronald Todd reported transactions for?
Phio Pharmaceuticals Corp.
When was Plott Ronald Todd's latest insider buy?
buy at Phio Pharmaceuticals Corp. on Aug 19, 2026 valued at $17,100.
When was Plott Ronald Todd's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.